Antiplatelet pathways development. Panel discussion.
Ballenger
J
J
Yale University, USA.
Olin
J W
JW
Brass
L M
LM
Orland
B I
BI
Cannon
E
E
Rich
S J
SJ
Dresdale
A
A
Stemple
C
C
Moreo
K
K
Zusman
R
R
D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000517:prevention & control; D019091:Critical Pathways; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy / Q000517:prevention & control*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D020521:Stroke / Q000188:drug therapy / Q000517:prevention & control*; D014481:United States
D010975:Platelet Aggregation Inhibitors